Callan Family Office, LLC
Family OfficePosition in IQV — Iqvia Holdings Inc.
CIK 1938970
RADNOR, PA
Position in IQV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,747,481
+$160,777 QoQ
Shares Held
9,044
-2.8% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#436
of 1,082 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IQV Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Callan Family Office, LLC holds $27,416,772 across 17 Diagnostics & Research names. IQV ranks #6 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
16,644 | $8,344,635 | |
| 2 | DHR |
Danaher Corp /De/
|
20,031 | $3,815,504 | |
| 3 | A |
Agilent Technologies, Inc.
|
16,725 | $2,221,581 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
3,531 | $1,858,859 | |
| 5 | ILMN |
Illumina, Inc.
|
10,254 | $1,802,960 | |
| 6 | IQV |
Iqvia Holdings Inc.
This page
|
9,044 | $1,747,481 | |
| 7 | DGX |
Quest Diagnostics Inc
|
5,868 | $1,243,722 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
902 | $1,152,314 |
All Filings in IQV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,747,481 | 9,044 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,586,704 | 9,304 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,384,837 | 10,580 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $973,442 | 5,125 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $981,312 | 6,227 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $248,230 | 1,408 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $354,700 | 1,805 | Shares | Sole | 2025-02-07 | |
| No filing history on record for this holder in this stock. | ||||||